Our focus is to understand the mechanisms that allow zoonotic, sylvatic arthropod-borne viruses to jump species boundaries and cause disease. Shared lab account
Joined October 2019
- Tweets 928
- Following 325
- Followers 1,565
- Likes 1,051
319 Photos and videos
Nikos Vasilakis retweeted
Conducting real-time epidemiological research during a pandemic demands adaptability. In the AVISA study, we faced recruitment challenges, vaccination shifts, and logistical complexity. Progress relied on flexibility and coordination. resilient research requires rapid adaptation.
1
4
171
Nikos Vasilakis retweeted
In a disruptive environment, delay is the highest-risk strategy. Don’t wait for full clarity.
Another mistake is treating AI, workforce, and strategy as separate conversations. They are one and the same transformation.
1
2
9
490
Nikos Vasilakis retweeted
Congratulations to Dr. Shannan L. Rossi on being named the inaugural Associate Dean of Strategic Initiatives, @UTMBGSBS! We are grateful for her leadership as she helps advance the school’s strategic priorities and strengthen the impact of its academic and research programs.
1
2
163
Nikos Vasilakis retweeted
Our new study presents an integrated pipeline for rapid epitope-based pan-alphavirus vaccine design, combining immunoinformatics, structural modeling, and experimental validation to identify broadly immunogenic candidates.
Congratulations to Alice and the entire team @afversiani
1
2
12
636
Nikos Vasilakis retweeted
We report in Nature Medicine that the single-dose Butantan dengue vaccine showed 65% efficacy against symptomatic dengue and 80.5% protection against severe disease over 5 years, with a favorable safety profile in participants aged 2–59 in Brazil.
24
343
1,816
163,811
Αn important study long overdue!
Maternal dengue antibodies can have two effects in infants: early protection, followed by increased risk of severe disease between 5–12 months (antibody-dependent enhancement). In Brazil dengue rose sharply from 2000–2024, with peaks of severe risk at birth and around 7–8 months.
3
214
What a great day for the Houston Marathon. Great community of supporters, lots of fun and a nice cold weather. Congratulations to all runners! @utmbhealth @ASTMH @Rossi_viruslab
1
211
24 Dec 2025
Great collaborative work. Congratulations to all team members for th hard work!
23 Dec 2025
Intra-host population dynamics of chikungunya virus in humans and naturally infected Aedes mosquitoes reveal transmission-driven diversity academic.oup.com/ve/article/…
just published!
@ACAV_ASTMH @AgenciaFAPESP @famerp @Vasilakis_Lab
3
172
22 Dec 2025
22 Dec 2025
Standardization of Quantitative Plaque-Based Viral Assays for Orthoflavivirus Cacipacoré
✍ by Saivish et al.
➡️ mdpi.com/1999-4915/17/10/135…
2
7
698
Nikos Vasilakis retweeted
19 Nov 2025
Excellent seminar and motivational talk with Carla Saleh, her love for science radiates from her.
@SalehLabParis
1
34
1,322
31 Oct 2025
a monumental effort led by Peter Simmonds & Jens Kuhn to reorganize the Family Flaviviridae based on analysis of RNA-directed RNA polymerase (RdRP) hallmark gene sequences is finally out. Enjoy reading! #ICTV, @ASTMH @utmbhealth @sbviro @
9
270
10 Oct 2025
Delighted to see Marielena's manuscript on the "Standardization of Quantitative Plaque-Based Viral Assays for Orthoflavivirus Cacipacoré" published. A collaborative effort with colleagues on our drive to characterize a number of Brazilian neglected orthoflaviviruses.
1
266
7 Oct 2025
We Look forward welcoming you on October 14th for Prof. Kim's webinar "Development of Vaccines Against Alphaviruses and Flaviviruses". Register: zoomgov.com/webinar/register…. @create_neo @ASTMH @ACAV_ASTMH @sbviro @Virology_FAMERP @Rossi_viruslab
3
7
537
Nikos Vasilakis retweeted
A new ms is out!
Clinical and laboratory profiles of Oropouche virus disease from the 2024 outbreak in Manaus, Brazilian Amazon
Nice work with our friends from Fundacao Medicina Tropical Manaus
journals.plos.org/plosntds/a…
2
6
307
Nikos Vasilakis retweeted
29 Sep 2025
Time to Re-think Strategies—And Refocus on Team Skills
I’ll explore how to make that shift in the unique context of academic healthcare during my upcoming C-Suite Assembly talk.
It’s time to build organizations where collaboration, adaptability, and shared purpose drive performance and innovation.
1
4
18
1,530
15 Aug 2025
15 Aug 2025
1
4
457
22 Jul 2025
RIP Ozzy. What a life! Thank you for the music! @sbviro @Virology_FAMERP @ASTMH @ACAV_ASTMH. You live for ever in our hearts
1
5
302
18 Jul 2025
We look forward seeing you Aug 12 for our next webinar on Vector-Borne and Zoonotic Diseases. Dr Maringer will present "Virus-specific innate immune responses in Aedes aegypti". Register: lnkd.in/gJdiYGm7. @create_neo @ASTMH @sbviro @Virology_FAMERP @ACAV_ASTMH @utmbhealth
6
18
822
17 Jul 2025
If you were not able to join us for Prof. Christofferson's @RC_Epi webinar, you may see it here utmb.edu/createneo/seminars/…. @sbviro @utmbhealth @create_neo @ASTMH @ACAV_ASTMH @Virology_FAMERP
1
11
711